title: Adalimumab desensitization after anaphylactic reaction.
authors.forename: Oliviero
authors.initials: O
authors.lastname: Quercia
authors.forename: Francesca
authors.initials: F
authors.lastname: Emiliani
authors.forename: Francesco Giuseppe
authors.initials: FG
authors.lastname: Foschi
authors.forename: Giuseppe Francesco
authors.initials: GF
authors.lastname: Stefanini
mesh_terms: D000068879:Adalimumab; D000707:Anaphylaxis / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D008875:Middle Aged; D012882:Skin Tests; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab